New York, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs ...
Lidia Serina, PhD, head of Development Services at Simtra BioPharma Solutions, discusses the challenges with maintaining aseptic integrity in sterile injectable pharmaceutical manufacturing. Editor's ...
This report by Towards Healthcare, a sister firm of Precedence Research, provides a focused overview of the evolving CDMO aseptic filling solutions landscape, highlighting the forces shaping demand ...
The "Fill Finish Manufacturing Market - A Global and Regional Analysis: Focus on Product, End Users, and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering.
PARSIPPANY, N.J., Oct. 27, 2025 /PRNewswire/ -- Simtra BioPharma Solutions, a leading contract development and manufacturing organization (CDMO) specializing in sterile injectables, is making progress ...
Within the past few years, key players have left the sterile manufacturing business. Can new technology and investment revitalize this critical market? The past five years have been troubled ones for ...
Injectable drug delivery is the mode of introduction of a drug directly into the bloodstream of a patient. Drugs are directly injected into the bloodstream of patients, owing to which they need to be ...
BRIDGEWATER, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the“Company”), an American biopharmaceutical ...
Pfizer has increased its position in the $7 billion-plus market for sterile injectable drugs with a $360 million agreement to buy New Jersey-based InnoPharma. The US pharma giant wants a bigger slice ...
Undergraduate students recently visited the SMU to aseptically manufacture lipid nanoparticles. Credit: Nathaniel Milton. WEST LAFAYETTE, Ind. — A mobile laboratory that Eli Lilly and Company used to ...
Jubilant Pharmova subsidiary and contract manufacturer Jubilant HollisterStier LLC (JHS) has launched a $132 million new sterile fill and finish line at its Spokane manufacturing facility in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results